Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports.
about
Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescentsAssociation between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trialsSelective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety reviewDapoxetine: a new option in the medical management of premature ejaculationGenome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatientsRisk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort studyPerspectives on the efficacy of antidepressants for child and adolescent depressionCognitive behavioral therapy for suicidal behaviors: improving patient outcomesThe International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise AlgorithmThe drug treatment of premature ejaculationPsychiatric Emergencies: Assessing and Managing Suicidal Ideation.Effects of vilazodone on suicidal ideation and behavior in adults with major depressive disorder or generalized anxiety disorder: post-hoc analysis of randomized, double-blind, placebo-controlled trialsInformation about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDsAntidepressants and Suicide Risk: A Comprehensive OverviewDepression, suicidality and antidepressants: A coincidence?Advances in treating premature ejaculation.Tolerability and safety of fluvoxamine and other antidepressants.Health advisories and patterns of patient monitoring among new users of antidepressant medications.An Update of the International Society of Sexual Medicine's Guidelines for the Diagnosis and Treatment of Premature Ejaculation (PE).Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review.How have the selective serotonin reuptake inhibitor antidepressants affected suicide mortality?Dapoxetine for premature ejaculation.Did regulators fail over selective serotonin reuptake inhibitors?Antidepressant prescription and suicide rates: effect of age and genderChallenges in conducting psychiatry studies in IndiaAntidepressant prescribing and suicides in emilia-romagna region (Italy) from 1999 to 2008: an ecological study.Antidepressant use and risk of suicide and attempted suicide or self harm in people aged 20 to 64: cohort study using a primary care databaseSales of antidepressants, suicides and hospital admissions for depression in Veneto Region, Italy, from 2000 to 2005: an ecological studyAntidepressants and suicide: what is the balance of benefit and harm.Death and dependence: current controversies over the selective serotonin reuptake inhibitors.Suicide and self-harm following prescription of SSRIs and other antidepressants: confounding by indication.Best practice elements of multilevel suicide prevention strategies: a review of systematic reviews.Suicide and antidepressants: what current evidence indicates.Depression, antidepressants and suicidality: a critical appraisal.Pharmacotherapy of suicidal behavior in bipolar disorder.Psychiatric drug trials and placebo.ACNP Task Force report on SSRIs and suicidal behavior in youth.Ethical issues in psychopharmacologyCitalopram and suicidality in adult major depression and anxiety disorders.Antidepressants and suicidal behavior in bipolar disorder.
P2860
Q24244127-42547F7F-15F9-4F46-B444-4794B4C922E4Q24556639-418280D7-44B1-4864-A222-8D017DCB48BDQ24556640-0B418195-2541-48EB-B2B2-1FDDDBE7DAFDQ24601186-2C66699B-8159-48AC-9435-11E9312F2B8DQ24650926-AD05A3B5-2261-452D-A369-7E2B090F9A70Q24678875-EAC01B52-0F84-41FD-B26D-C53C75B67D10Q24812722-A355FDED-2E49-416D-8B8B-DB8B6508C486Q26752788-1FDF4950-44C7-407A-91D8-3AE9F6FB99AAQ28066714-CE25D25F-C0B0-4E09-84B0-01EE392671ECQ28072609-B574B276-E8C4-4E9C-899F-1B724907FE8DQ30234967-4855BB36-AE03-4E20-A9D3-81A15F21C801Q30491758-4E532581-509A-445A-BF62-25370C83B9AAQ33414008-E7AF64DC-06B9-4A12-A31B-FAF3651CC02BQ33664712-2C92FCB5-FAA4-41C5-9FFC-272179D32ACAQ33671068-B28C028B-E010-4F55-BC0B-210646D9EF3EQ33942072-F72F4524-2F33-4140-ABBF-114C56AED976Q33995120-DD156C84-F633-4855-A023-FB7D1E48E38EQ34001906-348B972F-8155-48E1-8514-42BEAD424C77Q34286787-8F364ADE-AD04-4765-B0B9-4C45631F508CQ34574031-2BCF6EE1-1C43-4974-9E44-7F7BB5B34207Q34575698-61402D53-CF5B-4D21-B3DF-91DB1923A136Q34620485-F393D70A-CBBE-49F9-90D4-51C7EB2D0824Q34718444-F8E669AA-43A3-468B-8732-B6396AAC0D35Q34764682-10B8E6B5-4EBB-4BD8-8DB2-490A3FDD6B5DQ34942029-1104B73A-CD55-4542-94DC-3392B3D62AD7Q35101182-658DDB68-F6B3-4B7F-8FB1-E1AAAF1B6D40Q35158151-26C2CE7F-ABF1-4A7A-9B01-77E5202EE94DQ35398237-E37DB2F9-61E0-473B-858D-E73E21EFD518Q35615293-18C48BCD-1DBF-48AA-BC64-66B4EB941C4EQ35660695-EE9A8EBC-C718-4E8E-A2A9-CCDB72CF9569Q35827193-E32ADEA8-175F-4383-98CF-82AB08150FA6Q35835977-8A164D05-3C09-4A71-B112-4642C1E176A8Q35964358-C54E0C26-481C-4E8C-BAE8-8F29F9DB6A05Q36028253-623A46A3-D918-46A4-AC87-70C9205B5125Q36195190-BD2BC28D-4E9D-4148-9F27-7B8E250027ABQ36272768-B90F58A2-D925-477A-9723-5C36F218BB50Q36327813-3FDAC288-2BC0-4F99-B120-7234B206A1C3Q36525508-F898F443-D848-4FEE-9A5D-3FBCB4E666A7Q36622342-237F63C8-EC6D-4732-BD83-365403EE7B6BQ36624146-B3836A72-24A8-4E08-86B8-669F98D99A98
P2860
Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Suicide rates in clinical tria ...... cebo: analysis of FDA reports.
@ast
Suicide rates in clinical tria ...... cebo: analysis of FDA reports.
@en
Suicide rates in clinical tria ...... cebo: analysis of FDA reports.
@nl
type
label
Suicide rates in clinical tria ...... cebo: analysis of FDA reports.
@ast
Suicide rates in clinical tria ...... cebo: analysis of FDA reports.
@en
Suicide rates in clinical tria ...... cebo: analysis of FDA reports.
@nl
prefLabel
Suicide rates in clinical tria ...... cebo: analysis of FDA reports.
@ast
Suicide rates in clinical tria ...... cebo: analysis of FDA reports.
@en
Suicide rates in clinical tria ...... cebo: analysis of FDA reports.
@nl
P2093
P921
P1476
Suicide rates in clinical tria ...... cebo: analysis of FDA reports.
@en
P2093
Russell Kolts
Shirin Khan
Walter A Brown
P304
P356
10.1176/APPI.AJP.160.4.790
P407
P577
2003-04-01T00:00:00Z